Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy:: a randomised double blind crossover trial

被引：48
作者：
Hürlimann, D
Chenevard, R
Ruschitzka, F
Flepp, M
Enseleit, F
Béchir, M
Kobza, R
Muntwyler, J
Ledergerber, B
Lüscher, TF
Noll, G
Weber, R [1 ]
机构：
[1] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland
来源：
HEART | 2006年 / 92卷 / 01期
关键词：
D O I：
10.1136/hrt.2004.056523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：110 / 112
页数：3
相关论文
共 5 条
[1]   Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 [J].
Fichtenbaum, CJ ;
Gerber, JG ;
Rosenkranz, SL ;
Segal, Y ;
Aberg, JA ;
Blaschke, T ;
Alston, B ;
Fang, F ;
Kosel, B ;
Aweeka, F .
AIDS, 2002, 16 (04) :569-577
[2]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003
[3]   Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors [J].
Périard, D ;
Telenti, A ;
Sudre, P ;
Cheseaux, JJ ;
Halfon, P ;
Reymond, MJ ;
Marcovina, SM ;
Glauser, MP ;
Nicod, P ;
Darioli, R ;
Mooser, V .
CIRCULATION, 1999, 100 (07) :700-705
[4]   Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease [J].
Schächinger, V ;
Britten, MB ;
Zeiher, AM .
CIRCULATION, 2000, 101 (16) :1899-1906
[5]   Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction [J].
Stein, JH ;
Klein, MA ;
Bellehumeur, JL ;
McBride, PE ;
Wiebe, DA ;
Otvos, JD ;
Sosman, JM .
CIRCULATION, 2001, 104 (03) :257-262
1